Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Jan;120(1):34-41.
doi: 10.1016/j.anai.2017.09.055. Epub 2017 Nov 7.

Immunologic, microbial, and epithelial interactions in atopic dermatitis

Patrick M Brunner  1 , Donald Y M Leung  2 , Emma Guttman-Yassky  3
Affiliations
Review

Immunologic, microbial, and epithelial interactions in atopic dermatitis

Patrick M Brunner et al. Ann Allergy Asthma Immunol. 2018 Jan.

Abstract

Objective: To provide an overview of studies contributing to the understanding of immunologic, microbial, and epithelial interactions in atopic dermatitis.

Data sources: PubMed literature review (2000-2017) and meeting abstracts from recent international dermatology conferences.

Study selections: Articles discussing primarily human disease.

Results: Clinical studies showed that atopic dermatitis is a type 2 immune-centered disease with a systemic inflammatory component but with heterogeneous treatment responses. This suggests that other factors are likely involved in shaping the skin disease phenotype, including microbial dysbiosis and epidermal barrier dysfunction.

Conclusion: Recent clinical investigation has significantly expanded our knowledge on disease pathogenesis in atopic dermatitis, and current and future clinical trials will most likely further help to elucidate this complex, heterogeneous skin disease.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.. “The roof is on fire” –
Immune cell subsets mediating local as well as potentially systemic inflammation.
Figure 2.
Figure 2.. Potential “driver” cytokines in AD.
Immune mediators that have been shown to contribute to AD skin inflammation (IL-4, IL-13, IL-31, IL-12/IL-23), and that are potentially involved in shaping the disease phenotype, that are currently being investigated in clinical trials (IL-22, IL-17).
See this image and copyright information in PMC

References

    1. Weidinger S, Novak N. Atopic dermatitis. Lancet 2016;387:1109–22. - PubMed
    1. Silverberg JI. Public Health Burden and Epidemiology of Atopic Dermatitis. Dermatol Clin 2017;35:283–9. - PubMed
    1. Bonness S, Bieber T. Molecular basis of atopic dermatitis. Curr Opin Allergy Clin Immunol 2007;7:382–6. - PubMed
    1. Flohr C, Mann J. New insights into the epidemiology of childhood atopic dermatitis. Allergy 2014;69:3–16. - PubMed
    1. Dharmage SC, Lowe AJ, Matheson MC, Burgess JA, Allen KJ, Abramson MJ. Atopic dermatitis and the atopic march revisited. Allergy 2014;69:17–27. - PubMed

Publication types